Effects of Endothelin-1 Eyedrops on the Retina in Rats

Eye disorder accompanied with chronic retinal microvascular obstruction, such as diabetic retinopathy, exists in many diseases. However, it is difficult to produce this model experimentally in the animal eye. Endothelin-1 eyedrops were prepared in order to examine whether the eyedrops affect the rat retina and whether we can produce an obstruction model. Endothelin-1 eyedrops diluted by artificial tears in seven stages from 4 × 10−5 M to 4 × 10−11 M were arranged. We administered this solution three times a day in the left eye of male Sprague-Dawley rats. Artificial tears alone were applied to the right eye as a control vehicle. After 2 weeks, rats were sacrificed under anesthesia and the retinal tissues were isolated. As an index to the action of endothelin- 1 eyedrops to the retina, the expressions of endothelin-A (ETA) and endothelin-B (ETB) receptors in the retina were compared in both eyes. Frozen sections of the retina were immunostained to reveal the distribution of the ETA and ETB receptors. We also examined ETA and ETB mRNA expression by quantitative real-time polymerase chain reaction. As a result, the expressions of ETA and ETB receptors are reduced with both immunostaining and the mRNA levels in the left eye, in which endothelin-1 eyedrops were applied at 4 × 10−5 M. It is suggested that endothelin-1 eyedrops affected the retina and the possibility of producing the experimental model of chronic microvascular obstruction in the rat retina.

[1]  S. Koevary Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. , 2003, Current drug metabolism.

[2]  M. Araie,et al.  Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation. , 2003, Investigative ophthalmology & visual science.

[3]  M. Yanagisawa,et al.  Elevated systemic levels of endothelin-1 and blood pressure correlate with blunted constrictor responses and downregulation of endothelin(A), but not endothelin(B), receptors in an animal model of hypertension. , 2002, Clinical science.

[4]  S. Lake,et al.  Accumulation of topically applied porcine insulin in the retina and optic nerve in normal and diabetic rats. , 2002, Investigative ophthalmology & visual science.

[5]  A. Fernandez-cruz,et al.  Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes , 2001, Brain Research.

[6]  E. Chavakis,et al.  Topical application of integrin antagonists inhibits proliferative retinopathy. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[7]  M. Araie,et al.  Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. , 2001, Investigative ophthalmology & visual science.

[8]  M. Sandberg,et al.  Endothelin-1-mediated retinal artery vasospasm and the rabbit electroretinogram. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[9]  A. Fernandez-cruz,et al.  Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment , 2000, Diabetologia.

[10]  T. Uchide,et al.  Gene expression of vasoactive intestinal contractor/endothelin-2 in ovary, uterus and embryo: comprehensive gene expression profiles of the endothelin ligand-receptor system revealed by semi-quantitative reverse transcription-polymerase chain reaction analysis in adult mouse tissues and during late , 1999, Journal of molecular endocrinology.

[11]  S. Bursell,et al.  Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. , 1996, Investigative ophthalmology & visual science.

[12]  T. Miyauchi,et al.  A new model of transient complete obstruction of retinal vessels induced by endothelin-1 injection into the posterior vitreous body in rabbits , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  T. F. Patton,et al.  Importance of the noncorneal absorption route in topical ophthalmic drug delivery. , 1985, Investigative ophthalmology & visual science.

[14]  M. Ota,et al.  Nicardipine modification of endothelin-1 effects on visual evoked potential. , 1997, Japanese journal of ophthalmology.